25 Pulmonary Embolism Clinical Trials in Pittsburgh, PA (2026)

Q: Are there pulmonary embolism clinical trials in Pittsburgh?

Yes, there are 25 pulmonary embolism clinical trials currently recruiting in Pittsburgh, PA.

Q: How do I join a clinical trial in Pittsburgh?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you.

Q: Are clinical trials in Pittsburgh free?

Yes, clinical trial participation is always free. Study-related treatments, medical tests, and doctor visits are provided at no cost.

Recruiting Pulmonary Embolism Studies in Pittsburgh

NCT06921603Recruiting

POCUS-Guided Diuresis for Decompensated Heart Failure

Heart failure occurs when the heart cannot pump blood effectively, leading to fluid buildup in the body. This can cause problems such as difficulty breathing, swelling, and extreme tiredness. In sever...

Pittsburgh, PANA588 participantsUniversity of Pittsburgh

View Study Details

NCT06351631Recruiting

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

The primary purpose of the study is to transition participants into an extension study to collect long-term safety and efficacy data. The study will include participants who are safely tolerating bome...

Pittsburgh, PAPHASE3400 participantsMerck Sharp & Dohme LLC

View Study Details

NCT06686121Recruiting

Improving Mobility After Revascularization in Peripheral Artery Disease

Lower extremity revascularization combined with supervised exercise significantly improves walking performance compared to revascularization alone in people who have PAD without limb threatening ische...

Pittsburgh, PAPHASE3386 participantsNorthwestern University

View Study Details

NCT06959277Recruiting

Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems

The goal of this clinical trial is to is to test whether Walkasins can help people with peripheral neuropathy maintain their balance better. The main question it aims to answer is whether participants...

Pittsburgh, PANA200 participantsRxFunction Inc.

View Study Details

NCT06588634Recruiting

The PERSEVERE Study

Randomized Controlled Trial of High-Risk Pulmonary Embolism Comparing FlowTriever System vs. Standard of Care...

Pittsburgh, PANA200 participantsInari Medical

View Study Details

NCT06614322Recruiting

SPENDD: Quantitative Sensory Testing and Analgesic Response for Painful Peripheral Neuropathy.

The goal of this clinical trial is to determine whether quantitative sensory testing (QST) can be used to classify participants into pain sub-groups and predict who will respond best to certain pain t...

Pittsburgh, PAPHASE2190 participantsUniversity of Rochester

View Study Details

NCT03546374Recruiting

Medtronic Terminate AF Study

The purpose of this study is to demonstrate the safety and effectiveness of the Cardioblate iRF and CryoFlex hand held devices for the treatment of non-paroxysmal atrial fibrillation (AF)....

Pittsburgh, PANA160 participantsMedtronic Cardiac Surgery

View Study Details

NCT07061574Recruiting

A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes

This multi-center randomized controlled trial will assess the safety and efficacy of ATG followed by either adalimumab or verapamil in preserving insulin secretion 2 years from randomization in person...

Pittsburgh, PAPHASE1120 participantsCity of Hope Medical Center

View Study Details

NCT06997588Recruiting

EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)

This study is designed to demonstrate the efficacy and assess safety and tolerability of oral daily alpelisib in participants with PIK3CA-related overgrowth spectrum (PROS)....

Pittsburgh, PAPHASE2104 participantsNovartis Pharmaceuticals

View Study Details

NCT04829058Recruiting

GYNEMESH PS Mesh Post Marketing Clinical Follow-Up Study

The objective of this retrospective and prospective, single-arm, observational, multicenter, post-market study is to evaluate outcomes in women who underwent surgery for vaginal or uterine prolapse wi...

Pittsburgh, PA100 participantsEthicon, Inc.

View Study Details

NCT05452889Recruiting

PET Image in PAH Patients

Pulmonary arterial hypertension (PAH) is mortal disease affecting the blood vessels of the lung. Despite its morbid prognosis, PAH is often misdiagnosed or ignored, with an average time of 44 months b...

Pittsburgh, PAEARLY_PHASE171 participantsStephen Y. Chan

View Study Details

NCT07654205Recruiting

Smartphone-based Intervention for Young Adults With ADHD

The primary goal of this clinical trial is to test if a smartphone-based intervention is feasible \& acceptable among young adults with ADHD who also engage in risky drinking behaviors. A secondary ai...

Pittsburgh, PANA70 participantsTraci Kennedy

View Study Details

NCT07142252Recruiting

Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus

This Phase 2 study is a 2-arm, multi-center, double-masked (masking of the participant, care provider and investigator), placebo-controlled, 2:1 randomized trial design in new onset T1D participants (...

Pittsburgh, PAPHASE266 participantsNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

View Study Details

NCT06281665Recruiting

Treatment With Aspirin After Preeclampsia: TAP Trial

The objective of this research project is to conduct a single-site pilot trial to assess the feasibility and effect of low-dose aspirin to augment vascular recovery in the immediate postpartum period ...

Pittsburgh, PAPHASE460 participantsMalamo Countouris

View Study Details

NCT07037771Recruiting

A Phase 3 Study of Zodasiran in Adolescent and Adult Subjects With Homozygous Familial Hypercholesterolemia (YOSEMITE)

This multicenter, randomized, placebo-controlled study will evaluate the efficacy and safety of zodasiran subcutaneous (SC) injection in subjects 12 years of age and older with genetically or clinical...

Pittsburgh, PAPHASE360 participantsArrowhead Pharmaceuticals

View Study Details

NCT04786262Recruiting

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes

This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia....

Pittsburgh, PAPHASE352 participantsVertex Pharmaceuticals Incorporated

View Study Details

NCT07123155Recruiting

Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)

The purpose of this study is to evaluate the safety, pharmacodynamics (PD), and exploratory clinical efficacy of S-606001 in adult participants with LOPD as an add-on to ERT....

Pittsburgh, PAPHASE245 participantsShionogi

View Study Details

NCT07550127Recruiting

Peri-implantitis Management: Surgical and Maintenance Outcomes

The goal of this clinical trial is to learn how two standard surgical treatments for peri-implantitis affect inflammation around dental implants. Participants will be randomly assigned to receive rese...

Pittsburgh, PANA44 participantsUniversity of Pittsburgh

View Study Details

NCT04808505Recruiting

A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18

This is a Phase 3, open-label, multicenter study to evaluate the safety, efficacy, PK, PD, and immunogenicity of cipaglucosidase alfa/miglustat treatment in ERT-experienced and ERT-naïve pediatric sub...

Pittsburgh, PAPHASE336 participantsAmicus Therapeutics

View Study Details

NCT07270016Recruiting

Pilot-Testing Real-Time Engagement for Learning to Effectively Control Type 2 Diabetes

The goal of this study is to pilot test features of a new smartphone app and to gather feedback related to wearing a continuous glucose monitor (CGM) and a Fitbit device, as well as to obtain input on...

Pittsburgh, PANA30 participantsUniversity of Pittsburgh

View Study Details

NCT07050173Recruiting

Monitoring Patients With Repetitive Head Impact With Gamma-glutamylcysteine Supplementation

The goal of this clinical trial is to test whether the gamma - glutamylcystiene (GGC) oral supplement can reach the brain and subsequently increase antioxidant glutathione (GSH) level in people with r...

Pittsburgh, PAPHASE130 participantsPravat Mandal

View Study Details

NCT07489443Recruiting

Feasibility and Acceptability Trial to Reduce Tobacco and Cannabis Use During Pregnancy and Postpartum

Using both tobacco and cannabis during pregnancy is more common in minoritized groups and can make quitting smoking in pregnancy and remaining smoke free postpartum difficult. Investigators will test ...

Pittsburgh, PANA25 participantsUniversity of Pittsburgh

View Study Details

NCT06874322Recruiting

Voiceitt for People With Impairments in Speech

The primary objective of this pilot study is to evaluate the feasibility and preliminary effectiveness of the Voiceitt app in improving communication for individuals with speech impairments due to con...

Pittsburgh, PANA20 participantsUniversity of Pittsburgh

View Study Details

NCT07282847Recruiting

A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late Onset Pompe Disease (PROGRESS-GT LOPD)

This is a single-arm, open-label, dose-escalation study to evaluate the safety, tolerability and efficacy of a single intravenous infusion of AB-1009 in adult participants with late-onset Pompe diseas...

Pittsburgh, PAPHASE112 participantsAskBio Inc

View Study Details

NCT06832410Recruiting

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

This study will evaluate the efficacy, safety, and tolerability of VX-880 in participants with Type 1 Diabetes (TID) with a kidney transplant....

Pittsburgh, PAPHASE310 participantsVertex Pharmaceuticals Incorporated

View Study Details

About Pulmonary Embolism Clinical Trials in Pittsburgh

Pulmonary embolism (PE) is a blockage of an artery in the lungs, usually caused by blood clots that travel from the deep veins of the legs. It can be life-threatening and requires immediate medical attention. Treatment includes anticoagulants and in severe cases, thrombolytic therapy.

There are currently 25 pulmonary embolism clinical trials recruiting participants in Pittsburgh, PA. These studies are seeking a combined 3,079 participants. Research is being sponsored by University of Pittsburgh, Merck Sharp & Dohme LLC, Northwestern University and 17 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Pulmonary Embolism Clinical Trials in Pittsburgh — FAQ

Are there pulmonary embolism clinical trials in Pittsburgh?

Yes, there are 25 pulmonary embolism clinical trials currently recruiting in Pittsburgh, PA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Pittsburgh?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pittsburgh research site will contact you about next steps.

Are clinical trials in Pittsburgh free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pittsburgh studies also compensate for your time and travel.

What pulmonary embolism treatments are being tested?

The 25 active trials in Pittsburgh are testing new therapies including novel drugs, biologics, and treatment approaches for pulmonary embolism.

Data updated July 18, 2026 from ClinicalTrials.gov